Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):251–259. doi: 10.1097/QAI.0000000000002252

Table 2.

Demographics and chi-square comparisons between common variables in CHARTER and NNTC subsamples.

CHARTER Cell counts NNTC Cell counts χ2 df

Male 949 (77.7%) 643 (80.6%) 2.46 1
Female 273 (22.3%) 155 (19.4%)
Caucasian/White 515 (42.1%) 350 (43.9%) 97.45* 3*
African American/Black 565 (46.2%) 242 (30.3%)
Hispanic 109 (8.9%) 184 (23.1%)
Other 33 (2.7%) 22 (2.8%)
History of methamphetamine abuse/dependence present 202 (16.7%) 41 (7.9%) 22.78* 1*
History of methamphetamine abuse/dependence absent 1010 (83.3%) 475 (92%)
History of cocaine abuse/dependence present 497 (41.0%) 84 (16.3%) 98.74* 1*
History of cocaine abuse/dependence absent 715 (59.0%) 431 (83.7%)
History of alcohol abuse/dependence present 655 (54.0%) 89 (17.3%) 197.86* 1*
History of alcohol abuse/dependence absent 557 (46.0%) 424 (82.7%)
History of viral hepatitis present 557 (45.8%) 178 (33.9%) 21.29* 1*
History of viral hepatitis absent 659 (54.2%) 347 (66.1%)
History of hypertension present 513 (42.2%) 125 (23.7%) 54.39* 1*
History of hypertension absent 703 (57.8%) 403 (76.3%)
History of hyperlipidemia present 362 (29.6%) 86 (16.3%) 34.09* 1*
History of hyperlipidemia absent 859 (70.4%) 440 (83.7%)
History of diabetes present 132 (10.8%) 67 (12.7%) 1.35 1
History of diabetes absent 1,089 (89.2%) 459 (87.3%)
No current ARV treatment 168 (13.8%) 95 (12.0%) 169.69* 3*
ARV naive 196 (16.1%) 0 (0%)
Non-cART 89 (7.3%) 129 (16.3%)
cART 767 (62.9%) 566 (71.6%)

χ2 = chi-square value, df = degrees of freedom, and

*

= p < .05.